Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 4/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.45 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11124160 | 0.83 | CHRNB2 (0.49) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL7588607 | 0.80 | CYP2D6 (0.73) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL19038337 | 0.79 | BCHE (0.72) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL8523613 | 0.75 | BCHE (0.40) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL3756230 | 0.75 | CYP3A4 (0.38) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL3756225 | 0.75 | CYP3A4 (0.38) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL3757483 | 0.75 | CYP3A4 (0.38) | CYP3A4CYP1A2CYP2D6BCHEMAOB | |
| SCHEMBL28750100 | 0.75 | CHRNB4 (0.68) | BCHEMAOBCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL9672067 | 0.73 | DRD3 (0.47) | CYP3A4CYP1A2CYP2D6KDM4E | |
| SCHEMBL25153263 | 0.72 | CYP3A4 (0.57) | CYP3A4CYP1A2CYP2D6BCHEMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0634932-B1 | METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF MUSCARINIC ANTAGONISTS | ALLERGAN INC (US) | 2002-06-19 | — | — | EP | disclosed |
| US-5716952-A | TOPICAL APPLICATION | ALLERGAN (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0634932-A1 | METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF MUSCARINIC ANTAGONISTS | ALLERGAN, INC. (US) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993018772-A1 | METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF MUSCARINIC ANTAGONISTS | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | disclosed |